Concepedia

Gulfem D. Guler

GD

Statistics

Publications

13

Citations

1.4K

H-Index

12

Active since

2006

Affiliations

Constellation Pharmaceuticals (United States)(Current)

Vanderbilt University

Molecular Oncology (United States)

Active Motif (United States)

Gulfem D. Guler is an author at Constellation Pharmaceuticals (United States) specializing in molecular biology, molecular oncology, and oncology.

ORCID

Publications per year

2006–2024

13

Publications

13

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 357 citations · Full text

, , +14

Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure

Gulfem D. Guler, Charles Tindell, Robert Pitti et al. · Cancer Cell · 2017 · 277 citations · Full text

, , +12

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

Gulfem D. Guler, Yuhong Ning, Chin‐Jen Ku et al. · Nature Communications · 2020 · 186 citations · Full text

, , +17

An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition

Brian Egan, Chih-Chi Yuan, Madeleine Craske et al. · PLoS ONE · 2016 · 167 citations · Full text

, , +17

Mass Spectrometric Quantification of Histone Post-translational Modifications by a Hybrid Chemical Labeling Method

Tobias M Maile, Anita Izrael-Tomasevic, Tommy K. Cheung et al. · Molecular & Cellular Proteomics · 2015 · 124 citations · Full text

, , +17

1–5 of 13